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_____________________________________________________________________________  
 Several diarylamines in the benzo[b]thiophene series were prepared by palladium catalyzed 
amination of ethyl 3-bromobenzo[b]thien-2-yl carboxylate with anilines and 5-aminoindole, in 
good to high yields using Pd(OAc)2, BINAP, Cs2CO3 in toluene. The presence of the ester group 
in the position 2 of the benzo[b]thiophene moiety increases the yields and lowers the heating 
times when compared with reactions using 3-bromobenzo[b]thiophene. When aminopyridines, 
instead of anilines, were used the ligand and the solvent need to be changed to XANTHPHOS 
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and dioxane in the amination reaction. From 2-aminopyridine a one pot C-N coupling and 
intramolecular cyclization involving the nitrogen of the pyridine, with lost of ethanol, occurred 
giving an interesting fluorescent tetracyclic heteroaromatic compound. The  antimicrobial 
activity, the minimal inhibitory concentration (MIC) and structure-activity relationships (SAR) 
were evaluated. A selectivity with low MICs was observed against Bacillus Cereus and good 
results were also obtained against Candida albicans. The acids obtained by hydrolysis of the 
ester group, as non proteinogenic α,β-unsaturated β-amino acids can be incorporated in a peptide 
chain to induce conformational constraints.  
__________________________________________________________________ 
 
Introduction 
 
Benzo[b]thiophenes are important heterocycles either as biological active molecules or as 
luminescent components used in organic materials.[1] One of the most important drug based on 
the benzo[b]thiophene system is Raloxifene which was approved by the U.S. Food and Drug 
Administration for the prevention and treatment of osteoporosis in postmenopausal women.[2] 
Extensive research is now in course for other potential applications of this drug, namely for the 
treatment of Alzheimer’s disease.[3] In the same series a number of  3-(4-
pyridinyl)aminobenzo[b]thiophenes, which are selective serotonine re-uptake inhibitors, were 
prepared and may be useful in the treatment of central nervous system disorders, including 
obsessive compulsive disorders.[4] 
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Recently we have been interested in the palladium-catalyzed aryl amination of 
benzo[b]thiophenes either in the benzene or in the thiophene ring to obtain the corresponding 
diarylamines and in some cases the tetracyclic aromatic compounds resulting from 
intramolecular cyclizations.[5]  We have been able to establish that under the same C-N 
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coupling[6] conditions [Pd(OAc)2 (3mol%), Cs2CO3 (1.4 equiv) and BINAP (4mol%) in toluene] 
it was possible to obtain either primary amines[5b]   or diarylamines[5b,c] in the benzene ring of the 
benzo[b]thiophene moiety. The same conditions were not effective for the amination of 3-
bromobenzo[b]thiophene with ortho-bromoanilines where tBuONa, higher amounts of  
Pd(OAc)2 and BINAP were required.[5c] In this work we extend the scope of the former 
conditions to the coupling of ethyl 3-bromobenzo[b]thien-2-yl carboxylate 1a (electron-
deficient) and 3-bromobenzo[b]thiophene 1b (relatively electron-rich) with aromatic amines. For 
the coupling with aminopyridines other conditions were required as already described by other 
authors for heteroaromatic amines.[7] The antimicrobial activity and minimal inhibitory 
concentration (MIC) of some of the compounds prepared against bacteria and against Candida 
albicans together with structure-activity relationships (SAR) were evaluated. The acids obtained 
by hydrolysis of the ester group as non-proteinogenic α,β unsaturated β-amino acids can be 
incorporated into peptides to induce conformational constraints which can help in the study of 
the structure of proteins. 
Results and Discussion 
 
The precursor ethyl 3-bromobenzo[b]thien-2-yl carboxylate 1a, was prepared from the 
corresponding 3-aminocompound using tBuONO and CuBr2.[8] The latter was synthesized by 
reacting  2-cianonitrobenzene with ethylthioglycolate (Scheme 1).[9] 
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C-N couplings 
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Compound 1a was coupled with several anilines and with 5-aminoindole in the same 
conditions to give diarylamines 2 in good to high yields (Scheme 2). When 5-aminoindole was 
used as coupling component, after 5h of heating the yield of the coupled product was only 40% 
while leaving the reaction overnight the yield increased to 63%. In order to compare yields, two 
reactions were performed using 3-bromobenzo[b]thiophene 1b. The presence of the ester group 
in the 2-position increases the reaction yields and lowers the heating times (Scheme 2). 
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Under the same conditions 2 and 3-aminopyridines didn’t react. Changing the conditions to the 
ones used for the coupling of heteroaromatic amines by other authors[7] afforded the interesting 
tetracyclic compound 4 from 2-aminopyridine and  the diarylamine 5 from 3-aminopyridine 
(Scheme 3). The former resulted of a C-N coupling followed by an intramolecular cyclization 
involving the nitrogen atom of the pyridine ring with lost of ethanol. For the synthesis of 
compound 5 in good yield more time and higher amounts of Pd were needed, Pd(OAc)2 being 
also effective as Pd source. 
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Compound 4 as a planar compound can intercalate in the DNA bases acting as an anti-tumor 
compound and/or as a biomarker due to its fluorescence (Fig.1). It  showed a λem(max) at 435 nm 
and a relative quantum yield of fluorescence in dichloromethane   φdcm = 0.13, which was 
determined by the standard method[11] with 9,10-diphenylanthracene in ethanol as reference 
(φEtOH = 0.95),[12] using λexc 368 nm and applying equation 1. This excitation wavelength (λexc) 
was chosen from the absorption spectrum of compound 4 (see experimental) after verifying that 
when λexc 387 nm was used the compound was already emiting at lower wavelenghts. 
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Figure 1. Fluorescence spectrum of compound 4 in dichlorometane (10-6 M) (λexc 368nm) 
showing a λem  435 nm. 
 
Φs = ArFsns
2
AsFrnr
2 Φr            Equation 1 
A- absorbance at the excitation wavelength of the solutions in dcm (s), in EtOH (r). 
F - integrated emission area. 
n - refraction index of the solvents used.  
Subscripts refer to the reference (r) or sample (s) compound. 
 
The diarylamine 5 showed only a residual fluorescence (λexc 362 nm) with a λem (max) at 431 
nm and a neglectable quantum yield of fluorescence in dichloromethane (φdcm = 0.0008) 
relatively to the same reference compound in ethanol. 
 
Hydrolysis of the ester group 
 
The corresponding acids 6a and 6b were obtained in almost quantitative yield by hydrolysing 
the diarylamines 2a and 2b with NaOH in EtOH/H2O followed by acidification with HCl 
(Scheme 2). The β-aminoacids α, β-unsaturated 6a,b thus obtained can be inserted into peptides 
to induce conformational constraints which can help in the study of the structure of proteins. 
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Cyclization attempts of the acids and esters 
 
The acid 6a was submitted to unsuccessfull attempts of cyclization with PPA and Al2O3 acidic 
in order to obtain the corresponding acridinones. The acids are very polar and they didn’t 
dissolve in PPA even when it was pre-heated. When compound 6b was melted before addition, 
decarboxylation to compound 3a occurred quantitatively with the heat. Using acidic Al2O3, 
which some of us have used as acid catalyst and water retainer in chromenization reactions,[10] in 
dioxane at 110 oC overnight, decarboxylation occurred from 6a to 7 (Scheme 4). When the 
reaction was performed at 60 oC for 3 days, starting material and compound 7 in a little extent 
(formed as time passed) were isolated. 
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The ester 2a was submitted to Friedel-Crafts conditions described for the synthesis of cyclic 
constrained analogues of Raloxifene, resuting from diaryl compounds involving the position 4 of 
the benzo[b]thiophene moiety and possessing an ester group in the 3 position,[3] but in our case 
only demethylation to the hydroxyl compound 8 occurred (Scheme 5). The same conditions were 
applied to the fluoro compound 2c but no reaction took place.  
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It seems that the diarylamine moiety doesn’t give a good activation for the methods tried in the 
ester compounds. The easy decarboxylation with the temperature is also a problem for the 
cyclization of the corresponding acids. 
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In vitro antimicrobial activity and SAR 
 
A screening of antibacterial activities using two Gram negative (Escherichia coli CECT 101 
and Pseudomonas aeruginosa CECT 108) and two Gram positive bacteria (Bacillus subtilis 
CECT 498 and Bacillus cereus CECT 148) and antifungal using Candida albicans (CECT 1394) 
was performed for some of the compounds obtained and the minimal inhibitory concentration 
(MIC in µg/mL) was determined (Table 1) using an adaptation of agar streak dilution method 
based on radial diffusion.[13] Suspensions  of the microorganism were prepared to contain 
approximately 108 cfu/mL and the plates were inoculated. A stock solution of the synthesized 
compound (1000 µg/mL) in DMSO was prepared and graded dilutions of the tested compounds 
were incorporated in a cavity (depth 3mm, diameter 4mm) made in the center of the petridish 
(nutrient agar for antibacterial activity and sabouraud dextrose agar medium for antifungal 
activity). The plates were incubated at 37 oC (for bacteria) and at 30 oC (for fungi) for 24h in 
duplicate. In the same conditions different concentrated solutions of Ampiciline, 
Chloramphenicol (antibacterial) and Cyclohexamide (antifungal) in DMSO were used as 
standards. The MIC was considered to be the lowest concentration of the tested compound which 
inhibits growth of bacteria or fungi on the plate. The diameters of the inhibition zones 
corresponding to the MICs are presented in Table 1. Positive control using only inoculation and 
negative control using only DMSO in the cavity were carried out.  
The compounds tested were not active against the Gram negative bacteria and Bacillus 
subtilis but only against Bacillus cereus. Table 1 shows the MICs for B.cereus and C.albicans as 
an evaluation of the antimicrobial activity of the tested compounds. 
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Table 1. Antimicrobial activity of some of the synthesized compounds. 
 
Compounds 
MIC in µg/mL    (Zone of inhibition in mm ) 
Bacillus cereus                 Candida albicans 
  CECT 148                            CECT 1394 
2a 3.13 (14) 100 (8) 
8 3.13 (10) 100 (8) 
2b 3.13 (11) 100 (5) 
6b 3.13 (7)  50 (7) 
2c 3.13 (12) 200 (7) 
3b 3.13 (14)   50 (8) 
4 1.56 (10)       12.5 (10) 
5          1.56 (8)     12.5 (8) 
Ampiciline 3.13 (13) ______ 
Choramphenicol          3.13 (8) ______ 
Cyclohexamide ______     12.5 (5) 
CECT-Spanish type culture collection of Valencia University 
 
From the analysis of Table 1 it is possible to conclude that all the compounds exhibit low 
MICs for B. cereus and that compounds containing the pyridine ring 4 and 5 show the lowest 
MIC (1.56 µg/mL) even lower than the MIC for the antibacterial compounds. For the same 
compounds the lowest MICs (12.5 µg/mL) were also observed against C. albicans and are 
comparable to Cyclohexamide. The presence of the acid group in compound 6b lowers the MIC 
from 100 to 50 µg/mL against C. albicans when compared with compound 2b. Compound 2c 
shows the highest MIC against C. albicans (200 µg/mL) but without the ester group the 
corresponding fluoro compound 3b has a much more lower MIC  (50 µg/mL). 
 
Conclusions: 
 
Several diarylamines were prepared using the same C-N coupling conditions from electron 
deficient or relatively rich benzo[b]thienylbromides with aromatic amines. The use of 
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XANTHPHOS as ligand was needed to couple ethyl 3-bromobenzo[b]thien-2-yl carboxylate 
with aminopyridines. A tetracyclic heteroaromatic fluorescent compound was obtained from the 
coupling of 2-aminopyridine by a one pot C-N coupling and intramolecular cyclization with lost 
of ethanol. 
Attempts to cyclize the esters and acids to acridinones were unsuccessful so far. 
In vitro antimicrobial activity, MICs and SAR were evaluated. A selectivity against B. cereus 
was observed with low MICs. Against C. Albicans good results were also obtained especially for 
the compounds having a pyridine ring. 
 
Experimental Section 
 
General Remarks: Melting points were determined on a Gallenkamp apparatus and are uncorrected. The 1H 
NMR spectra were measured on a Varian Unity Plus at 300 MHz. Spin-spin decoupling techniques were used to 
assign the signals. The 13C NMR spectra were measured in the same instrument at 75.4 MHz (using DEPT θ 45º).  
The IR spectra were recorded as nujol mulls on a Perkin-Elmer 1600-FTIR spectrophotometer. The UV spectra were 
recorded  on a Schimadzu UV-250 1PC, UV-vis recording spectrophotometer.               
 Elemental analyses were determined on a LECO CHNS 932 elemental analyser. Mass spectra (EI) and HRMS 
were made by the mass spectrometry service of University of Vigo-Spain or on a Micromass Autospec 3F. 
The fluorescence studies were performed  on a spectrofluorimeter Spex Fluorolog 1680 Double Spectrometer.  
Column chromatography was performed on Macherey-Nagel silica gel 230-400 mesh. Petroleum ether refers to 
the boiling range 40-60 oC. Ether refers to diethyl ether. When solvent gradient was used the increase of polarity 
was done gradually from neat petroleum ether to mixtures of ether/petroleum ether increasing 10% of ether until the 
isolation of the product.  
 
Ethyl 3-bromobenzo[b]thien-2-yl carboxylate 1a: Following the literature methods[8,9] compound 1a was obtained 
in 60 % overall yield as an orange solid,  m. p. 60-62 oC . νmax 1725 (C=O) cm-1.   1H NMR (CDCl3): δ = 1.45 (t, J = 
7 Hz, 3H, CO2CH2CH3 ),  4.45 (q, J = 7 Hz, 2H, CO2CH2CH3), 7.49-7.58 (m, 2H, ArH), 7.80-7.86 (m, 1H, ArH), 
7.97-8.02 (m, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 14.18 (CH3), 61.77 (CH2), 114.70 (C), 122.53 (CH), 125.17 
(CH), 125. 50 (CH),  127.99 (CH), 138.53 (C),  139.17 (C), 161.34 (C=O) ppm. C11H9BrO2S (285.16): calcd. C 
46.33, H  3.18, S 11.24; found C 46.69, H 3.56, S 11.48.  
 
 
General procedure for C-N cross coupling with anilines and 5-aminoindole: A dry  Schlenk tube was charged, 
under Ar, with dry toluene (3-5mL), compound 1a or 1b, Pd(OAc)2 (3 mol%), racBINAP (4mol%), Cs2CO3 
(1.4equiv). and at the end the amine. The reaction was stirred and heated at 100 oC for several hours (Scheme 2). 
After cooling water and ether were added and the phases were separated. The aqueous phase was extracted with 
more ether and the organic phases were collected, dried (MgSO4), filtered and the removal of the solvent gave an 
oil, after addition of MeOH to remove traces of toluene. The oil was submitted to column chromagraphy. 
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Ethyl 3-[(4-methoxyphenyl)amino]benzo[b]thien-2-yl carboxylate 2a: From compound 1a (300 mg, 1.05 mmol), 
p-anisidine (130 mg, 1.05 mmol) and  column chromatography using solvent gradient from neat petroleum ether to 
10% ether/petroleum ether, product 2a (263 mg, 76%) was obtained as an orange solid. Recrystallization from 
ether/petroleum ether gave yellow crystals, mp 87-89 ºC. νmax 3305 (NH), 1667 (C=O) cm-1.  1H NMR (CDCl3): δ = 
1.42 (t, J = 7 Hz, 3H, CO2CH2CH3 ), 3.83 (s, 3H, OCH3), 4.38 (q, J = 7 Hz, 2H, CO2CH2CH3), 6.86 (d, J = 8.7 Hz, 
2H, 2xArH), 7.06-7.11 (m, 3H, ArH), 7.22 (d, J = 8 Hz, 1H, ArH), 7.35-7.40 (1H, m, Ar-H), 7.73 (d, J = 8 Hz, 1H, 
ArH), 8.81 (s, 1H, NH)  ppm. 13C NMR (CDCl3): δ = 14.44 (CH3), 55.46 (OCH3), 60.69 (CH2), 103.77 (C), 114.22 
(2xCH), 123.15 (CH), 123.18 (CH), 124.90 (2xCH), 125.59 (CH), 127.45 (CH), 131.58 (C), 135.01 (C), 140.23 (C), 
147.60 (C), 156.69 (C), 165.74 (C=O) ppm. C18H17NO3S (327.40): calcd. C 66.04, H 5.23, N 4.28, S 9.79; found C 
66.00, H 5.43, N 4.48, S 9.79.  
 
Ethyl 3-[(2,4-dimethoxyphenyl)amino]benzo[b]thien-2-yl carboxylate 2b: From compound 1a (300 mg, 1.05 
mmol), 2,4-dimethoxyaniline (161 mg, 1.05 mmol) and  column chromatography using solvent gradient from neat 
petroleum ether to 20% ether/petroleum ether, product 2b (300 mg, 80%) was obtained as an orange solid. 
Recrystallization from ether/petroleum ether gave yellow crystals, mp 95-96 ºC. νmax 3319 (NH), 1666 (C=O) cm-1. 
1H NMR (CDCl3): δ = 1.42 (t, J = 7 Hz, 3H, CO2CH2CH3 ), 3.83 (s, 3H, OCH3), 3.85 (s, 3H, OCH3), 4.38 (q, J = 7 
Hz, 2H, CO2CH2CH3), 6.37 (dd, J = 8.7 and 2.7 Hz, 1H, 5’-H), 6.56 (d, J = 2.7 Hz, 1H, 3’-H), 6.93 (d,  J = 8.7 Hz, 
1H, 6’-H), 7.08-7.14 (m, 1H, ArH), 7.34-7.41 (m, 2H, ArH), 7.72 (d, J = 8 Hz, 1H, ArH), 8.58 (s, 1H, NH) ppm. 13C 
NMR (CDCl3): δ = 14.45 (CH3), 55.55 (OCH3), 55.69 (OCH3), 60.66 (CH2), 99.21 (CH), 103.41 (CH) 104.34 (C), 
123.12 (CH), 123.16 (CH), 123.17 (CH), 124.30 (C), 125.35 (CH), 127.40 (CH), 131.91 (C), 140.06 (C), 147.08 
(C), 153.19 (C), 157.16 (C), 165.55 (C=O) ppm. C19H19NO4S (357.42): calcd. C 63.85, H 5.36, N 3.92, S 8.97; 
found C 63.68, H 5.49, N 4.04, S 8.96.  
 
Ethyl 3-[(4-fluorophenyl)amino]benzo[b]thien-2-yl carboxylate 2c:  From compound 1a (150 mg, 0.526 mmol), 
4-fluoroaniline (64.0 mg, 0.526 mmol) and  column chromatography using solvent gradient from neat petroleum 
ether to 20% ether/petroleum ether, product 2c (105 mg, 63%) was obtained as a yellow solid. Recrystallization 
from ether/petroleum ether gave light yellow crystals, mp 119-121 ºC. νmax 3294 (NH), 1668 (C=O) cm-1. 1H NMR 
(CDCl3): δ = 1.42 (t, J = 7 Hz, 3H, CO2CH2CH3 ), 4.39 (q, J = 7 Hz, 2H, CO2CH2CH3), 6.97-7.17 (m, 5H, ArH),  
7.25-7.29 (m, 1H, ArH), 7.38-7.44 (m, 1H, ArH), 7.76 (d, J = 8 Hz, 1H, ArH), 8.75 (s, 1H, NH) ppm. 13C NMR 
(CDCl3): δ = 14.40 (CH3), 60.90 (CH2), 106.19 (C) 115.73 (d, J = 22.7 Hz, 3’ and 5’-CH), 123.27 (CH), 123.39 
(CH), 123.80 (d, J = 8 Hz, 2’ and 6’-CH), 125.37 (CH), 127.57 (CH), 131.60 (C), 138.27 (d, J = 2.8 Hz, 1’-C), 
140.09 (C), 146.41 (C), 159.45 (d,  J = 242.7 Hz, CF), 165.55 (C=O) ppm. C17H14FNO2S (315.36): calcd. C 64.75, 
H 4.47, N 4.44, S 10.17; found C 64.40, H 4.77, N 4.37, S 10.36.  
 
Ethyl 3-[(5-indole)amino]benzo[b]thien-2-yl carboxylate 2d:  From compound 1a (250 mg, 0.877 mmol), 5-
aminoindole (116 mg, 0.877 mmol), heating for 21h and  column chromatography using solvent gradient from neat 
petroleum ether to 50% ether/petroleum ether, product 2d (155 mg, 63%) was obtained as an orange  solid. 
Recrystallization from ether/petroleum ether gave yellow crystals, mp 166-168 ºC. νmax 3382 (NH), 3307 (NH), 
1631 (C=O) cm-1. 1H NMR (CDCl3): δ = 1.43 (t, J = 7 Hz, 3H, CO2CH2CH3 ), 4.39 (q, J = 7 Hz, 2H, CO2CH2CH3), 
6.49-6.51 (m, 1H, ArH),  6.95-7.00 (m, 1H, ArH), 7.07 (dd , J = 8.4 and 2.1 Hz, 1H, 6’-H), 7.14 (d, J = 8 Hz, 1H,  
ArH) 7.25-7.27 (m, 1H, ArH), 7.30-7.34 (m, 2H, ArH), 7.46 (d, J = 2.1 Hz, 1H, 4’-H), 7.72 (d, J = 8 Hz, 1H,  ArH), 
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8.20 (s, 1H, indole-NH) 9.01 (s, 1H, NH) ppm. 13C NMR (CDCl3): δ = 14.48 (CH3), 60.59 (CH2), 102.56 (C) 102.72 
(CH), 111.30 (CH) 115.90 (CH), 119.91 (CH)  123.03 (CH), 123.04 (CH), 125.17 (CH), 125.91 (CH), 127.39 (CH), 
128.17 (C), 131.79 (C), 133.58 (C), 134.49 (C)  140.32 (C), 148.52 (C), 165.89 (C=O) ppm. C19H16N2O2S (336.41): 
calcd. C 67.84, H 4.79, N 8.33, S 9.53; found C 67.56, H 4.90, N 8.29, S 9.32.  
 
3-[(2,4-Dimethoxyphenyl)amino]benzo[b]thiophene 3a: From compound 1b (249 mg, 1.17 mmol), 2,4-
dimethoxyaniline (180 mg, 1.17 mmol) and column chromatography using solvent gradient from neat petroleum 
ether to 10% ether/petroleum ether, product 3a (200 mg, 60%) was obtained as an oil. 1H NMR (CDCl3): δ = 3.83 
(s, 3H, OCH3), 3.94 (s, 3H, OCH3), 6.10 (s, 1H, NH), 6.50 (dd, J = 8.7 and 2.7 Hz, 1H, 5’-H), 6.64 (d, J = 2.7 Hz, 
1H, 3’-H), 6.90 (s, 1H, 2-H), 7.22 (d,  J = 8.7 Hz, 1H, 6’-H), 7.41-7.44 (m, 2H, 7 and 4-H), 7.76-7.80 (m, 1H, ArH), 
7.86-7.90 (m, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 55.53 (OCH3), 55.56 (OCH3), 99.24 (CH), 103.74 (CH) 
104.11 (C), 116.08 (CH), 120.19 (CH), 123.01 (CH), 123.61 (CH), 124.67 (CH), 127.40 (C), 134.27 (C), 136.08 
(C), 138.73 (C), 149.09 (C), 153.96 (C) ppm. MS m/z (%) 287 (M++2, 7), 286 (M++1, 20), 285 (M+, 100), 270 (M+-
15, 51), 138 (19). HRMS M+ C16H13NO2S: calcd. 285.082298; found 285.082351. 
 
3-[(4-Fluorophenyl)amino]benzo[b]thiophene 3b:  From compound 1b (300 mg, 1.41 mmol), 4-fluoroaniline (156 
mg, 1.41 mmol) and  column chromatography using solvent gradient from neat petroleum ether to 10% 
ether/petroleum ether, product 3b (127 mg, 40%) was obtained as a white solid. Recrystallization from 
ether/petroleum ether gave colourless crystals, mp 87-89 ºC. νmax 3388 (NH) cm-1.1H NMR (CDCl3): δ = 5.68 (s, 
1H, NH), 6.91 (s, 1H, 2-H),  6.98 (s, 4H, 2’, 3’, 5’ and 6’-H),  7.38-7.41 (m, 2H, ArH), 7.64-7.67 (m, 1H, ArH), 
7.83-7.86 (m, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 107.83 (CH), 115.90 (d, J = 22.5 Hz, 3’ and 5’-CH), 118.05 
(d, J = 8 Hz, 2’ and 6’-CH),  120.41 (CH), 123.25 (CH), 123.91 (CH),  124.92 (CH), 134.20 (C), 135.77 (C) 138.97 
(C), 140.64 (C), 157.37 (d,  J = 238.7 Hz, CF) ppm. C17H10FNS (243.30): calcd. C 69.11, H 4.14, N 5.76, S 13.18; 
found C 69.00, H 4.35, N 5.76, S 13.05.  
 
General procedure for C-N cross coupling with aminopyridines: A dry  Schlenk tube was charged, under Ar, 
with dry 1,4-dioxane (3-5mL), compound 1a, Pd2dba3 (3mol%Pd) or Pd(OAc)2 (6 mol%), XANTHOPS (4mol%), 
Cs2CO3 (1.4equiv). and at the end the aminopyridine (1.1 equiv). The reaction mixture was stirred and heated at 100 
oC for several hours (Scheme 3). After cooling water and ether were added and the phases were separated. The 
aqueous phase was extracted with more ether and the organic phases were collected, dried (MgSO4), filtered and  
removal of  solvent gave an oil or a solid. The oil was submitted to column chromagraphy. 
 
6-Oxo-6H-benzo[b]thieno[3,2-d]pyrido[1,2-a]pyrimidine 4:  From compound 1a (200 mg, 0.702 mmol), 2-
aminopyridine (73.0 mg, 0.772 mmol) product 4 was obtained as a beije solid (100 mg, 60%). Recrystallization 
from ether gave light beije crystals, mp 211-213 ºC. νmax 1693 (C=O) cm-1. λmax (CH2Cl2) (ε dm3mol-1cm-1) 387 
(6066), 368 (7238), 303 (2062), 276 (14842), 257 (18772) nm. 1H NMR (DMSO-d6): δ = 7.31-7.38 (m, 1H, ArH),  
7.58-765 (m, 1H, ArH), 7.69-7.76 (m, 1H, Ar-H) 7.81-7.93 (m, 2H, ArH), 8.16 (d, J = 8 Hz,  1H, ArH), 8.37 (broad 
d, J = 8 Hz,  1H, ArH) 9.01 (broad d, J = 8 Hz,  1H, ArH) ppm. 13C NMR (DMSO-d6): δ = 113.21 (C), 115.46 (CH), 
123.80 (CH), 124.01 (CH), 125.52 (CH), 125.91 (CH), 126.32 (CH), 130.06 (CH), 133.93 (C), 135.98 (CH), 141.23 
(C), 149.28 (C), 153.38 (C), 154.05 (C) ppm. MS (EI) m/z (%) 252 (M+, 100), 224 (M+-CO, 35). HRMS M+ 
C15H11N2OS: calcd. 252.035735; found 252.035591. 
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Ethyl 3-(3-aminopyridine)benzo[b]thien-2-yl carboxylate 5:  From compound 1a (200 mg, 0.702 mmol), 3-
aminopyridine (73.0 mg, 0.772 mmol) and  column chromatography using solvent gradient from neat petroleum 
ether to neat ether, product 5 (127 mg, 40%) was obtained as an orange solid. Recrystallization from ether/petroleum 
ether gave yellow light crystals, mp 112-114 ºC. νmax 3293 (NH), 1661 (C=O) cm-1.  λmax (CH2Cl2) (ε dm3mol-1cm-1) 
362 (12099), 263 (22764) 225 (13469) nm. 1H NMR (CDCl3): δ = 1.43 (t, J = 7 Hz, 3H, CO2CH2CH3 ), 4.40 (q, J = 
7 Hz, 2H, CO2CH2CH3), 7.18-7.24 (m, 2H, ArH),  7.29-7.38 (m, 2H, ArH), 7.42-7.48 (m, 1H, ArH), 7.79-7.71(d, , J 
= 8.1 Hz, 1H, ArH), 8.33 (broad d, J = 4.5 Hz, 1H, Ar-H), 8.44  (d, J = 2.4 Hz, 1H, 2’-H), 8.70 (s, 1H, NH) ppm. 
13C NMR (CDCl3): δ = 14.35 (CH3), 61.17 (CH2), 109.34 (C), 123.41(2xCH), 123.83 (CH), 125.00 (CH), 127.28 
(CH), 127.74 (CH), 131.59 (C), 139.01 (C), 139.87 (C), 142.79 (CH), 144.10 (CH), 144.36 (C), 165.26 (C=O) ppm. 
C16H14O2N2S (298.34): calcd. C 64.41, H 4.73, N 9.39, S 10.75; found C 64.09, H 4.95, N 9.24, S 10.70.  
 
General procedure for the hydrolysis of the ester group: Compounds 2a or 2b in ethanol (10-20 mL) were 
treated with a NaOH 30% aqueous solution (5 equiv.). The mixture was stirred and  heated to reflux using a water 
bath for some hours following the reaction by TLC. After cooling the ethanol was evaporated under reduced 
pressure and to the solid obtained water was added and then HCl 1N  till the precipitation of the acids 6a or 6b 
which were obtained by filtration and drying at 50 oC. 
 
3-[(4-Dimethoxyphenyl)amino]benzo[b]thien-2-yl carboxylic acid 6a: From compound 2a (150 mg, 0.459 
mmol), product 6a (131 mg, 96%) was obtained as yellow solid. Recrystallization from ether gave yellow crystals, 
mp 148-150 ºC. νmax 3300 (NH), 1642 (C=O) cm-1. 1H NMR (CDCl3): δ = 3.85 (s, 3H, OCH3), 6.89 (d, J = 9 Hz, 
2H, 2xArH), 7.05 -7.19 (m, 4H, ArH), 7.40 (broad t, J = 8 Hz, 1H, ArH), 7.53 (d, J = 8 Hz, 1H, ArH), 8.84 (s, 1H, 
NH) ppm. C16H13NO3S (299.35): calcd. C 64.20, H 4.38, N 4.69, S 10.71; found C 64.03, H 4.59, N 4.66, S 10.66.  
 
3-[(2,4-Dimethoxyphenyl)amino]benzo[b]thien-2-yl carboxylic acid 6b: From compound 2b (360 mg, 1.01 
mmol), product 6b (328 mg, 99%) was obtained as yellow solid. Recrystallization from ether gave yellow crystals, 
mp 152-154 ºC. νmax 3354 (NH), 1688 (C=O) cm-1. 1H NMR (DMSO-d6): δ = 3.76 (s, 6H, 2xOCH3), 6.45 (dd, J = 
8.7 and 3 Hz, 1H, 5’-H), 6.68 (d, J = 3 Hz, 1H, 3’-H), 6.89 (d, J = 8.7 Hz, 1H, 6’-H), 7.13-7.17 (m, 2H, ArH), 7.40-
7.45 (m, 1H, ArH), 7.88 (d, J = 8.1 Hz, 1H, ArH), 8.53 (s, 1H, NH) ppm. 13C NMR (DMSO-d6): δ = 55.42 (OCH3), 
55.76 (OCH3), 99.45 (CH), 103.75 (C) 104.24 (CH), 123.21(C), 123.63 (CH), 123.67(CH), 123.79 (CH), 124.42 
(CH), 127.73 (CH), 131.52 (C), 139.08(C), 146.47 (C), 153.33 (C), 157.33 (C), 166.51 (C=O) ppm. C17H15NO4S 
(329.37): calcd. C 61.99, H 4.59, N 4.25, S 9.74; found C 61.99, H 4.83, N 4.31, S 9.60.  
 
Cyclization attempts: 
 
3-[(4-Methoxyphenyl)amino]benzo[b]thiophene 7: To a solution of compound 6a (50.0 mg, 0.190 mmol) in dry 
CH2Cl2 (3mL) in a Schlenk tube, Al2O3 acidic Brockman I (10 equiv.) was added and the suspension was left 
stirring overnight at 110 oC under Ar. After cooling the alumina was removed by filtration and the solvent removal 
gave  product 7 (46 mg, quantitative yield) as a solid m.p. 102-104 oC. 1H NMR (CDCl3): δ = 3.81(s, 3H, OCH3), 
5.70 (broad s, 1H, NH), 6.76 (s, 1H, 2-H),  6.87 (d, J = 9 Hz, 2H, 2xArH), 7.05 (d, J = 9 Hz, 2H, 2xArH), 7.35-7.42 
(m, 2H, ArH), 7.64-7.69 (m, 1H, ArH), 7.81-7.85 (m, 1H, ArH) ppm. 13C NMR (CDCl3): δ = 55.62 (OCH3), 104.60 
(CH), 114.74 (2xCH), 119.44 (2xCH), 120.19 (CH), 123.20 (CH), 123.74 (CH), 124.79 (CH), 133.95 (C), 136.95 
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(C), 137.59 (C), 139.01 (C), 154.42 (C) ppm. MS (EI) m/z (%) 255 (M+, 80), 240 (M+-Me, 100). HRMS M+ 
C15H13NOS: calcd. 255.0718; found 255.0726. 
 
Ethyl 3-[(4-hydroxyphenyl)amino]benzo[b]thien-2-yl carboxylate 8: To a solution of compound 2a (100 mg, 
0.301 mmol)  in dry CH2Cl2 (10 mL) at 0 oC it was added a solution of BBr3 in CH2Cl2  1M (1.6 mmol, 1.6 mL). The 
solution went green and it was left stirring at 0 oC for 2h. A saturated solution of NaHCO3 was added slowly and the 
extractions were done using  CH2Cl2 . The organic phases were collected, dried, filtered and removal of solvent gave 
a yellow green solid (95.0 mg, quantitative yield). Recrystallization from ether/petroleum ether  gave yellow green 
crystals, mp 152-154 oC. νmax 3330 (NH), 1630 (C=O) cm-1. 1H NMR (CDCl3): δ = 1.41 (t, J = 7 Hz, 3H, 
CO2CH2CH3 ), 4.39 (q, J = 7 Hz, 2H, CO2CH2CH3), 4.90 (broad s, 1H, OH), 6.81 (d, J = 8.7 Hz, 2H, 2xArH), 7.01-
7.20 (m, 3H, ArH), 7.2 (d, J = 8.2 Hz, 1H, ArH), 7.35 (broad t, J = 8.2 Hz, 1H, ArH), 7.72 (d, J = 8.2 Hz, 1H, ArH), 
8.77 (s, 1H, NH) ppm. 13C NMR (CDCl3): δ = 14.47 (CH3), 60.78 (CH2), 115.83 (CH), 123.22 (4xCH), 123.25 
(CH), 125.17 (CH), 125.64 (CH), 127.52 (CH), 131.63 (C), 135.24 (C), 140.32 (C), 147.56 (C), 147.57 (C) 152.71 
(C), 165.84 (C=O) ppm. MS (EI) m/z (%) 313 (M+, 50), 311 (M+-2, 90), 267 (100), 239 (80) 210 (90). HRMS M+ 
C17H15NO3S: calcd. 313.0773; found 313.0760. 
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